Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions

Obesity, Abdominal

Interventions

DIETARY_SUPPLEMENT

NAD+ precursor

NAD+ precursor supplementation (Nicotinamide, Nicotinamide Riboside, or Nicotinamide Mononucleotide)

OTHER

Placebo

Oral placebo daily intake for 6 months

Trial Locations (1)

Turku PET Centre, Turku

All Listed Sponsors

lead

University of Turku

OTHER

NCT06627868 - Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue | Biotech Hunter | Biotech Hunter